- Set targets and quality indicators, assess current gaps and prioritize stroke care in global, national, and regional health plans.
- Expand and invest in infrastructures for essential stroke services, including stroke units and intravenous thrombolysis.*
- Expand and invest in (capital) infrastructures for advanced stroke services: mechanical thrombectomy.**
- Increase the necessary skills in the health workforce.
- Make sure that payment models provide adequate reimbursement of essential and advanced stroke care.
- Develop a strategy to realize the potential savings from essential and advanced acute stroke care.
The joint WSO-Philips policy paper entitled ‘Time for a revolution in stroke care’ can be downloaded here.
‘Time is brain’ is the mantra in stroke care, because every minute saved when treating a major stroke results in millions of saved brain cells. Investing in stroke centers and WHO recommended treatments including mechanical thrombectomy, a minimally invasive technique for removing the blood clot from the brain artery that caused the stroke, has the potential to improve hundreds of thousands of lives. Clinical trials show that mechanical thrombectomy is a highly effective treatment for the most debilitating strokes, and if treated in time, the impact is such that major strokes have become ‘curable’.
Yet, access to thrombectomy remains the exception rather than the norm in global stroke care. For example, an average of around 7% of all ischemic stroke patients in the European region received this treatment in 2019. Policymakers have a crucial opportunity to accelerate the rollout of this essential, advanced stroke care alongside the necessary associated infrastructure and policy to support.
Professor Sheila Martins, President of the World Stroke Organization, said: “The impact of thrombolysis and thrombectomy on stroke patient outcomes has been established for more than a decade. More recent research has also demonstrated the cost-effectiveness of these treatments in low-income, middle-income and high-income countries. Investing in acute stroke care provides governments with an unmissable opportunity to reduce the burden of stroke to individuals and society and to deliver on their UN SDG3 commitment. The time to act is now.”
Carla Goulart Peron, Philips’ Chief Medical Officer, said: “Stroke is a leading cause of death and disability worldwide. The burden of stroke on patients, their families, the healthcare system, and society, is huge. The time is now for a coordinated approach to revolutionize stroke care, bringing together investment in care and treatment, infrastructure, awareness and a focus on effective policymaking. The benefits are significant, both for healthcare systems and societies, and most importantly in delivering better care for millions of patients worldwide.”
Philips and the WSO signed a two-year partnership in October 2023 focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge. In May of this year, Philips supported the WSO side-event at the 77th World Health Assembly (WHA) entitled United in Action to Transform Stroke Care, which was the first ever WHA satellite session dedicated specifically to stroke.
